Repurpose drugs for new indications
The opportunities and challenges in using biomarker data in drug discovery and development.
Identifying proteins with causal links to neurological diseases
Read more
Candidate drugs based on plasma proteomics of patients with severe COVID-19
Read more
In silico selection and MOA analysis of candidate drugs for ischemic stroke
Read more
Proteomics at the heart of multiomics strategies
Systems biology approaches addressing multiple molecular and cellular components are adding vital insights into the dynamic biology underlying human health and disease.
Hear from industry experts on how proteomics is changing the way we develop new drugs and study disease.
The power of proteomics in multiomic studies
Download the eBook, ‘Proteomics at the heart of multiomic studies’ to learn more about how this trend is the next step in advancing precision medicine.
2947
Biomarker assays
~881 million
Protein data points generated
1182
Publications listed on website